Akin Advises Coller Capital as Sole Lead Investor on £500 Million Pharmacy2U Continuation Fund
Contact:
(London) – Akin advised Coller Capital as sole lead investor on a £500 million single-asset continuation fund managed by G Square Healthcare Private Equity LLP, supporting the continued ownership and growth of Pharmacy2U, a leading U.K. online pharmacy. The transaction represents one of the most significant GP-led secondary transactions in the European health-tech sector.
Coller Capital led the transaction alongside a syndicate of institutional investors, with G Square and existing shareholders also reinvesting in the business. The bespoke continuation vehicle was established to provide liquidity to existing investors while enabling continued investment in Pharmacy2U's next phase of growth.
The Akin team was led by investment management partners Daniel Quinn and Qasam Mahmood. The wider team included investment management counsel Benedict Watson and associate Masha Novikova; tax counsel Mohammed Natha; and antitrust and international competition partner Davina Garrod.
Akin is a leading international law firm with more than 1,000 lawyers in offices throughout the United States, Europe, Asia and the Middle East.
